Lumen Bioscience: Lumen Bioscience Awarded $8.8 million from U.S. Department of Defense to Develop Fast-Acting, Intranasal Countermeasure Against Respiratory Viruses

Lumen Bioscience today announced a new $8.8 million project funded by the U.S. Department of Defense (DOD) to develop and test a prototype broad-spectrum, fast-acting intranasal powder for treatment and prevention of known and emerging viral respiratory infections.